ClinConnect ClinConnect Logo
Search / Trial NCT03925389

Outcome Analysis in Septorhinoplasty

Launched by FRANK DECLAU · Apr 19, 2019

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Nasal Function Septorhinoplasty Patient Reported Outcome Rhinomanometry Acoustic Rhinometry Peak Nasal Inspiratory Flow Esthetics

ClinConnect Summary

This clinical trial is studying the outcomes of a surgical procedure called septorhinoplasty, which is done to improve both the appearance of the nose and to relieve nasal obstruction. Researchers want to see how this surgery affects patients by measuring their experiences before and after the procedure using various questionnaires that focus on nasal function, aesthetic satisfaction, and quality of life. They will also conduct some functional tests to assess breathing improvements.

To participate in this study, individuals must be at least 18 years old and have been experiencing nasal obstruction for at least a year due to identifiable issues, such as a deviated septum or enlarged nasal turbinates. Unfortunately, those with a recent nasal fracture, recent nasal surgery, or those unable to answer questions due to mental or physical challenges will not be eligible. Participants can expect to share their experiences through surveys and tests, helping researchers understand the benefits and challenges of septorhinoplasty for patients like them. This study is currently recruiting participants of all genders.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • at least 18 years old
  • Patients eligible for external septorhinoplasty: patients seen in consultation because of nasal obstruction were evaluated. Patients who had symptoms of nasal obstruction for at least 1 year that were the result of an identifiable anatomical cause such as septal deviation, turbinate hypertrophy, internal valve collapse, or external valve collapse were included in the study.
  • Exclusion Criteria:
  • \< 18 years
  • mental or physical incapacity to answer the questionnaires
  • nasal fracture or surgery in the past year
  • nasal cocaine use in the past year

About Frank Declau

Frank Declau is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and innovation. With a focus on improving patient outcomes, the organization collaborates with leading healthcare professionals and institutions to design and conduct rigorous clinical trials. Frank Declau emphasizes ethical practices, transparency, and adherence to regulatory standards, ensuring that all trials are conducted with the utmost integrity. The sponsor aims to contribute valuable insights to the scientific community and enhance the development of new therapies that address unmet medical needs.

Locations

Antwerp, , Belgium

Patients applied

0 patients applied

Trial Officials

Frank Declau, MD, PhD

Principal Investigator

Universiteit Antwerpen

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials